Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc.（NTHI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NTHI · 截至 2026年6月9日
活动摘要
买入笔数
21
P-Purchase only
卖出笔数
10
近12个月
买卖比
2.10
Buy/Sell (by trades)
整体情绪
Neonc Technologies Holdings, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
NTHI 季度内部人买卖趋势
NTHI 内幕交易卖出 · NTHI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · NTHI CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NTHI 高管卖出股份 · NTHI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Nov 24, 2025 | Heshmatpour Amir F President · Director | Purchase | 6,000 | $39K | Form 4 |
| Nov 21, 2025 | Heshmatpour Amir F President · Director | Purchase | 4,000 | $26K | Form 4 |
| Nov 20, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Purchase | 1,100 | $7K | Form 4 |
| Jun 5, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Award | 133,000 | — | Form 4 |
| Jun 5, 2025 | Neman-Ebrahim Yousha Chief Clinical Officer | Award | 67,000 | — | Form 4 |
| May 22, 2025 | CHEN THOMAS C CEO · Director | Purchase | 2,709 | $20K | Form 4 |
| May 21, 2025 | CHEN THOMAS C CEO · Director | Purchase | 2,759 | $20K | Form 4 |
| May 22, 2025 | GARNETT KEITHLY CFO | Purchase | 675 | $5K | Form 4 |
| May 19, 2025 | GARNETT KEITHLY CFO | Purchase | 135 | $976 | Form 4 |
| May 12, 2025 | Delshad Jim Director | Purchase | 5,000 | $36K | Form 4 |
| Apr 17, 2025 | Delshad Jim Director | Purchase | 50 | $346 | Form 4 |
| Mar 26, 2025 | Delshad Jim Director | Purchase | 50 | $802 | Form 4 |
| May 13, 2025 | GARNETT KEITHLY CFO | Purchase | 90 | $631 | Form 4 |
| May 12, 2025 | CHEN THOMAS C CEO · Director | Purchase | 400 | $3K | Form 4 |
| May 15, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,500 | $11K | Form 4 |
| May 14, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,000 | $7K | Form 4 |
| May 13, 2025 | Heshmatpour Amir F President · Director | Purchase | 990 | $7K | Form 4 |
| May 12, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,400 | $10K | Form 4 |
| May 11, 2025 | Heshmatpour Amir F President · Director | Purchase | 1,600 | $12K | Form 4 |
| Mar 26, 2025 | Delshad Jim Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | GARNETT KEITHLY CFO · Director | Other | 687 | — | Form 4 |
| Mar 26, 2025 | GIANNOTTA STEVEN L. Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | CHIANG MING-FU (ALAN) Director | Award | 50,000 | — | Form 4 |
| Mar 26, 2025 | CHIANG MING-FU (ALAN) Director | Other | 5,994 | — | Form 4 |
| Mar 26, 2025 | Heshmatpour Amir F Director | Other | 3,996 | — | Form 4 |
Neman-Ebrahim Yousha
Chief Clinical Officer
日期
Nov 20
股数
1,100
均价
$6.69
总金额
$7K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NTHI 内幕交易
NTHI 内幕交易
Neonc Technologies Holdings, Inc.（NTHI）内幕交易数据来源于公司内部人（包括Heshmatpour Amir F (President · Director), Neman-Ebrahim Yousha (Chief Clinical Officer)）提交的SEC Form 4申报文件。过去12个月内，2位内部人向SEC提交了交易申报。NTHI内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Neonc Technologies Holdings, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NTHI 内幕交易 · 5个问题Neonc Technologies Holdings, Inc.（NTHI）的内部人包括高管和董事，如Heshmatpour Amir F (President · Director), Neman-Ebrahim Yousha (Chief Clinical Officer)等。过去12个月内，2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026